OBJECTIVES: The aim of this study is to evaluate the payers' perspectives on digitalization, the reimbursement process, and innovations in the health sector in Turkiye.

METHODS: Within the scope of the study, relevant public institutions, universities, insurance companies and non-governmental organizations were researched and 67 payers from the health sector were determined. A survey was created on Microsoft Forms to get the opinions of the stakeholders. The questionnaire was prepared on a 5-point Likert scale and consists of 2 parts (17 questions) titled Persona and Digital Affinity. The prepared questionnaire was sent to all payers via e-mail.

RESULTS: The questionnaire was filled by 12 payers. 50% of the participants work in the public, 33% in academia and 16% in the private sector. All participants support innovative treatments. 83% of the participants stated that they are open to digital communication. 50% of the participants stated that the most important output in the reimbursement process is clinical results. While most of the participants stated that they trusted clinical data created by pharmaceutical companies, they stated that they were neutral towards disease cost and cost-effectiveness studies.

CONCLUSIONS: It has been observed that payers support digitalization in the repayment process and think that some regulations are needed in the repayment process in Turkiye. There is a great need for policy adjustments by decision makers on indirect costs in Turkiye.